Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine and Multizonal Contact Lens for Myopia Control
NCT06765603Phase 2Not yet recruiting
- Sponsor
- Singapore National Eye Centre
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Modality
- Classical Binding Small Molecules
01
Overview
Phase 2, randomised trial of atropine in myopia (4 arms), sponsored by Singapore National Eye Centre. Primary endpoint: Change in spherical equivalent at 12 months. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06765603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765603.